Inhibitory CD8+ T cells in autoimmune disease

Area of Science:

• Immunology
• Autoimmune Diseases
• T Cell Biology

Background:

• Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) management faces challenges due to the dual role of adaptive immunity.
• Regulatory T cells (Tregs) are ideal targets for immunosuppression as they can suppress self-antigen responses.

Purpose of the Study:

• To explore the therapeutic potential of distinct CD8(+) suppressor T cell (Ts) subtypes for managing autoimmune diseases like RA and SLE.
• To investigate the mechanisms by which CD8(+) Ts exert suppressive functions in autoimmune models.

Main Methods:

• Evaluation of CD8(+)CD28(-)CD56(+) T cells in a human synovium xenograft model.
• Assessment of IL-16 secreting CD8(+) T cells in polyarthritis mouse models.
• Analysis of CD8(+) Ts induced by synthetic or histone peptides in SLE animal models.

Main Results:

• CD8(+)CD28(-)CD56(+) T cells suppressed rheumatoid inflammation via antigen-presenting cell (APC) conditioning.
• Adoptive transfer of IL-16 secreting CD8(+) T cells showed disease-inhibitory effects.
• CD8(+) Ts modulated tryptophan metabolism in APCs (IFNgamma-mediated) and utilized TGFbeta-Foxp3-PD1 pathways in SLE models, secreting TGFbeta to downregulate disease activity.

Conclusions:

• Specific CD8(+) T cell subtypes demonstrate potent immunosuppressive capabilities relevant to RA and SLE.
• Mechanisms involve APC modulation and key signaling pathways like TGFbeta-Foxp3-PD1.
• Disease-specific strategies are likely necessary to identify optimal CD8(+) Ts for diverse autoimmune syndromes.